Alessandro Fatica Selected Research

Long Noncoding RNA

1/2022	MALAT1-dependent hsa_circ_0076611 regulates translation rate in triple-negative breast cancer.
2/2018	Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer.
7/2015	C/EBPα-p30 protein induces expression of the oncogenic long non-coding RNA UCA1 in acute myeloid leukemia.
1/2015	Long Non-Coding RNAs: New Players in Hematopoiesis and Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alessandro Fatica Research Topics

Disease

18	Neoplasms (Cancer) 04/2023 - 08/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 05/2011
4	Carcinogenesis 10/2023 - 12/2008
4	Leukemia 04/2021 - 08/2009
3	Hematologic Neoplasms (Hematological Malignancy) 10/2013 - 08/2009
1	Triple Negative Breast Neoplasms 12/2023
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Adenocarcinoma of Lung 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2021
1	Thymus Neoplasms (Thymus Neoplasm) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Wilms Tumor (Wilm's Tumor) 01/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 04/2017
1	Carcinoma (Carcinomatosis) 07/2015
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 10/2013
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2013
1	Lymphoma (Lymphomas) 10/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2010

Drug/Important Bio-Agent (IBA)

7	RNA (Ribonucleic Acid)IBA 04/2023 - 01/2019
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2015
6	6-methyladenineIBA 12/2023 - 01/2019
6	MicroRNAs (MicroRNA)IBA 11/2020 - 12/2008
4	Long Noncoding RNAIBA 01/2022 - 01/2015
3	Messenger RNA (mRNA)IBA 01/2023 - 01/2021
3	N-methyladenosineIBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2022
2	MethyltransferasesIBA 12/2023 - 01/2021
2	PolyaminesIBA 10/2023 - 12/2020
2	Circular RNAIBA 01/2022 - 04/2017
1	Cytostatic AgentsIBA 10/2023
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	CarcinogensIBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	Mutant Proteins (Protein, Mutant)IBA 12/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	ChromatinIBA 02/2018
1	Competitive Endogenous RNAIBA 09/2016
1	CCAAT-Enhancer-Binding ProteinsIBA 07/2015
1	Polycomb Repressive Complex 2IBA 05/2011
1	Histone MethyltransferasesIBA 05/2011
1	OligonucleotidesIBA 07/2010

Therapy/Procedure

3	Therapeutics 12/2023 - 08/2009